Social Vulnerability and COVID-19 Vaccine in Spain
Abstract
:1. Introduction
2. Materials and Methods
Analysis
3. Results
4. Discussion and Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Khan, Y.H.; Mallhi, T.H.; Alotaibi, N.H.; Alzarea, A.I.; Alanazi, A.S.; Tanveer, N.; Hashmi, F.K. Threat of COVID-19 Vaccine Hesitancy in Pakistan: The Need for Measures to Neutralize Misleading Narratives. Am. J. Trop. Med. Hyg. 2020, 103, 603–604. [Google Scholar] [CrossRef]
- Cristea, D.; Zamfirache, I.; Zamfirescu, R.G. Vaccination against COVID-19 in Europe: A Typology Based on Cluster Analysis. Int. J. Environ. Res. Public Health 2022, 19, 8603. [Google Scholar] [CrossRef] [PubMed]
- Elsayed, M.; El-Abasiri, R.A.; Dardeer, K.T.; Kamal, M.A.; Htay, M.N.N.; Abler, B.; Marzo, R.R. Factors Influencing Decision Making Regarding the Acceptance of the COVID-19 Vaccination in Egypt: A Cross-Sectional Study in an Urban, Well-Educated Sample. Vaccines 2021, 10, 20. [Google Scholar] [CrossRef] [PubMed]
- Rodrigues, F.; Block, S.; Sood, S. What Determines Vaccine Hesitancy: Recommendations from Childhood Vaccine Hesitancy to Address COVID-19 Vaccine Hesitancy. Vaccines 2022, 10, 80. [Google Scholar] [CrossRef] [PubMed]
- Nguyen, K.H.; Srivastav, A.; Razzaghi, H.; Williams, W.; Lindley, M.C.; Jorgensen, C.; Abad, N.; Singleton, J.A. COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination—United States, September and December 2020. Am. J. Transplant. 2021, 21, 1650–1656. [Google Scholar] [CrossRef]
- Elgendy, M.O.; Abdelrahim, M.E.A. Public awareness about coronavirus vaccine, vaccine acceptance, and hesitancy. J. Med. Virol. 2021, 93, 6535–6543. [Google Scholar] [CrossRef]
- Galeotti, A.; Rogers, B.W. Strategic Immunization and Group Structure. Am. Econ. J. Microecon. 2013, 5, 1–32. [Google Scholar] [CrossRef] [Green Version]
- Böhm, R.; Betsch, C.; Korn, L. Selfish-rational non-vaccination: Experimental evidence from an interactive vaccination game. J. Econ. Behav. Organ. 2016, 131, 183–195. [Google Scholar] [CrossRef]
- Cucciniello, M.; Pin, P.; Imre, B.; Porumbescu, G.A.; Melegaro, A. Altruism and vaccination intentions: Evidence from behavioral experiments. Soc. Sci. Med. 2022, 292, 114195. [Google Scholar] [CrossRef]
- Flanigan, J. A Defense of Mandatory Vaccination. HEC Forum. Interdiscip. J. Hosp. Ethical. Leg. Issues 2014, 26, 5–25. [Google Scholar] [CrossRef]
- Pierik, R. Mandatory Vaccination: An Unqualified Defence. J. Appl. Philos. 2016, 35, 381–391. [Google Scholar] [CrossRef]
- Wang, X.; Kulkarni, D.; Dozier, M.; Hartnup, K.; Paget, J.; Campbell, H.; Nair, H. Usher Network for COVID-19 Evidence Reviews (UNCOVER) group. Influenza vaccination strategies for 2020-21 in the context of COVID-19. J. Glob. Health 2020, 10, 021102. [Google Scholar] [CrossRef] [PubMed]
- Bergstrand, K.; Mayer, B.; Brumback, B.; Zhang, Y. Assessing the Relationship Between Social Vulnerability and Community Resilience to Hazards. Soc. Indic. Res. 2015, 122, 391–409. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ge, Y.; Dou, W.; Zhang, H. A New Framework for Understanding Urban Social Vulnerability from a Network Perspective. Sustainability 2017, 9, 1723. [Google Scholar] [CrossRef] [Green Version]
- Watts, M.J.; Bohle, H.G. The space of vulnerability: The causal structure of hunger and famine. Prog. Hum. Geogr. 1993, 17, 43–67. [Google Scholar] [CrossRef]
- Ward, P.S.; Shively, G.E. Disaster risk, social vulnerability, and economic development. Disasters 2017, 41, 324–351. [Google Scholar] [CrossRef]
- Kourlaba, G.; Kourkouni, E.; Maistreli, S.; Tsopela, C.G.; Molocha, N.M.; Triantafyllou, C.; Koniordou, M.; Kopsidas, I.; Chorianopoulou, E.; Maroudi-Manta, S.; et al. Willingness of Greek general population to get a COVID-19 vaccine. Glob. Health Res. Policy 2021, 6, 3. [Google Scholar] [CrossRef]
- Lazarus, J.V.; Ratzan, S.C.; Palayew, A.; Gostin, L.O.; Larson, H.J.; Rabin, K.; Kimball, S.; El-Mohandes, A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021, 27, 225–228. [Google Scholar] [CrossRef]
- Lastrucci, V.; Lorini, C.; Stacchini, L.; Stancanelli, E.; Guida, A.; Radi, A.; Morittu, C.; Zimmitti, S.; Alderotti, G.; Del Riccio, M.; et al. COVID-19 Population Research Group; Bonaccorsi, G. Determinants of Actual COVID-19 Vaccine Uptake in a Cohort of Essential Workers: An Area-Based Longitudinal Study in the Province of Prato, Italy. Int. J. Environ. Res. Public Health 2022, 19, 13216. [Google Scholar] [CrossRef]
- Shore, D.A. Communicating in times of uncertainty: The need for trust. J. Health Commun. 2003, 8, 13–14. [Google Scholar] [CrossRef]
- Kuznetsova, L.; Diago-Navarro, E.; Mathu, R.; Trilla, A. Effectiveness of COVID-19 Vaccination Mandates and Incentives in Europe. Vaccines 2022, 10, 1714. [Google Scholar] [CrossRef] [PubMed]
- CIS Estudio N° 3259. Available online: https://www.cis.es/cis/opencm/ES/1_encuestas/estudios/ver.jsp?estudio=14599 (accessed on 19 June 2022).
- Costello, A.B.; Osborne, J.W. Exploratory Factor Analysis: Four recommendations for getting the most from your analysis. Pract. Assess. Res. Eval. 2005, 10, 1–9. [Google Scholar] [CrossRef]
- de Souza, C.D.F.; Machado, M.F.; do Carmo, R.F. Human development, social vulnerability and COVID-19 in Brazil: A study of the social determinants of health. Infect. Dis. Poverty 2020, 9, 124. [Google Scholar] [CrossRef] [PubMed]
- Snyder, B.F.; Parks, V. Spatial variation in socio-ecological vulnerability to COVID-19 in the contiguous United States. Health Place 2020, 66, 102471. [Google Scholar] [CrossRef]
- Oliveira, R.G.; Cunha, A.P.D.; Gadelha, A.G.D.S.; Carpio, C.G.; Oliveira, R.B.; Corrêa, R.M. Racial inequalities and death on the horizon: COVID-19 and structural racism. Cad. Saude. Publica 2020, 36, e00150120. [Google Scholar] [CrossRef]
- Karaye, I.M.; Horney, J.A. The Impact of Social Vulnerability on COVID-19 in the U.S.: An Analysis of Spatially Varying Relationships. Am. J. Prev. Med. 2020, 59, 317–325. [Google Scholar] [CrossRef]
- Dodd, R.H.; Cvejic, E.; Bonner, C.; Pickles, K.; McCaffery, K.J. Willingness to vaccinate against COVID-19 in Australia. Lancet Inf. Dis. 2020, 21, 318–319. [Google Scholar] [CrossRef]
- Thorneloe, R.; Wilcockson, H.; Lamb, M.; Jordan, C.H.; Arden, M. Willingness to receive a COVID-19 vaccine among adults at high-risk of COVID-19: A UK-wide survey. PsyArXiv 2020, 14, 1489–1499. [Google Scholar] [CrossRef]
- Barry, V. Patterns in COVID-19 vaccination coverage, by social vulnerability and urbanicity—United States, December 14, 2020–May 1, 2021. MMWR Morb. Mortal. Wkly. Rep. 2021, 2021, 70. [Google Scholar] [CrossRef]
- Brown, C.C.; Young, S.G.; Pro, G.C. COVID-19 vaccination rates vary by community vulnerability: A county-level analysis. Vaccine 2021, 39, 4245–4249. [Google Scholar] [CrossRef]
- Gidengil, C.A.; Parker, A.M.; Zikmund-Fisher, B.J. Trends in risk perceptions and vaccination intentions: A longitudinal study of the first year of the H1N1 pandemic. Am. J. Public Health 2012, 102, 672–679. [Google Scholar] [CrossRef] [PubMed]
- Cutter, S.L.; Boruff, B.J.; Shirley, W.L. Social Vulnerability to Environmental Hazards. Soc. Sci. Q. 2003, 84, 242–261. [Google Scholar] [CrossRef]
- Tierney, K. Social Inequality, Hazards, and Disasters. In On Risk and Disaster: Lessons from Hurricane; KatrinaRonald, J.D., Donald, F.K., Howard, K., Eds.; University of Pennsylvania Press: Philadelphia, PA, USA, 2011; pp. 109–128. [Google Scholar] [CrossRef]
- Doherty, M.; Schmidt-Ott, R.; Santos, J.I.; Stanberry, L.R.; Hofstetter, A.M.; Rosenthal, S.L.; Cunningham, A.L. Vaccination of special populations: Protecting the vulnerable. Vaccine 2016, 34, 6681–6690. [Google Scholar] [CrossRef] [Green Version]
- Tucker, J.S.; D’Amico, E.J.; Pedersen, E.R.; Garvey, R.; Rodriguez, A.; Klein, D.J. COVID-19 Vaccination Rates and Attitudes Among Young Adults With Recent Experiences of Homelessness. J. Adolesc. Health 2022, 70, 504–506. [Google Scholar] [CrossRef] [PubMed]
- Masson, C.L.; McCuistian, C.; Straus, E.; Elahi, S.; Chen, M.; Gruber, V.A.; Le, T.; Guydish, J. COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs. Drug Alcohol. Depend 2021, 225, 108812. [Google Scholar] [CrossRef]
- Jacobson, R.M.; Sauver, J.L.S.; Griffin, J.M.; MacLaughlin, K.L.; Rutten, L.J.F. How health care providers should address vaccine hesitancy in the clinical setting: Evidence for presumptive language in making a strong recommendation. Hum. Vaccines Immunother. 2020, 16, 2131–2135. [Google Scholar] [CrossRef] [Green Version]
- Ballard, M.; Bancroft, E.; Nesbit, J.; Johnson, A.; Holeman, I.; Foth, J.; Rogers, D.; Yang, J.; Nardella, J.; Olsen, H.; et al. Prioritising the role of community health workers in the COVID-19 response. BMJ Glob. Health 2020, 5, e002550. [Google Scholar] [CrossRef]
- World Health Organization; Fund (UNICEF) UNC. The Role of Community Health Workers in COVID-19 Vaccination: Implementation Support Guide; Report No.: WHO/2019-nCoV/NDVP/CHWs_role/2021.1; World Health Organization: Geneva, Switzerland, 2021; Available online: https://apps.who.int/iris/handle/10665/340986 (accessed on 22 October 2022).
- Peretz, P.J.; Islam, N.; Matiz, L.A. Community Health Workers and COVID-19—Addressing Social Determinants of Health in Times of Crisis and Beyond. New Engl. J. Med. 2020, 383, e108. [Google Scholar] [CrossRef]
Male | Female | p-Value * | ||
---|---|---|---|---|
Age (years) | 18–24 | 85 | 84 | 0.972 |
25–34 | 162 | 145 | ||
35–44 | 231 | 230 | ||
45–54 | 255 | 261 | ||
55–64 | 214 | 228 | ||
65–74 | 186 | 196 | ||
75–84 | 80 | 77 | ||
85–94 | 14 | 14 | ||
Employment status | Working | 800 | 748 | 0.000 |
Retired or pensioner | 306 | 277 | ||
Student | 40 | 48 | ||
Unemployed | 68 | 130 | ||
Studies | No education | 30 | 46 | 0.001 |
Primary | 71 | 109 | ||
Secondary 1st stage | 165 | 209 | ||
Secondary 2nd stage | 188 | 184 | ||
Vocational training | 249 | 214 | ||
Higher | 507 | 454 | ||
Others | 9 | 13 | ||
Subjective class identification | High/upper middle | 97 | 66 | 0.006 |
Middle | 620 | 627 | ||
Lower middle | 183 | 174 | ||
Working/Laborer | 119 | 100 | ||
Low/poor | 90 | 128 |
Component | ||
---|---|---|
1 | 2 | |
Fear of becoming ill | 0.614 | |
Concern about measures that may limit face-to-face contact and relationships with family, friends, and neighbors | 0.559 | |
Fear of not recovering their life as it was before the pandemic. | 0.746 | |
Fear of no longer being able to undertake life projects such as emancipation, starting a business, or traveling. | 0.622 | |
Concern and fear for the future | 0.692 | |
Grief over the loss of a family member, friend or acquaintance | 0.650 | |
Concern about losing their personal job or that of a family member | 0.784 | |
Fear of the possibility of losing your personal job or that of a family member | 0.767 | |
Uneasiness about not being able to meet their expenses (mortgages, rents, loans, utilities, telephony, etc.). | 0.764 |
Variable | Category | Standardized Residual | p-Value * | |
---|---|---|---|---|
Factor 1: High uncertainty | Factor 2: High fear | |||
Gender | Female | 3.3 | 2.2 | <0.001 |
Age | Less than 45 years old | 2.3 | 4.3 | <0.001 |
Employment status | Unemployed or performing unpaid work at home | 2.1 | 4.9 | <0.001 |
Studies | No education | 1.6 | 3.7 | <0.001 |
Primary | 1.8 | 4.1 | <0.001 | |
Subjective class identification | Low/poor | 2.1 | 4.1 | <0.001 |
Variable | Yes | No |
---|---|---|
Willingness to be vaccinated when it is your turn | 12.6% | 87.4% |
Does not trust the vaccine | 36.8% | 63.2% |
Do not believe it is effective | 10.3% | 89.7% |
Fear of health risks/side effects/collateral side effects | 31.0% | 69% |
Because they are unlikely to be contagious | 4.6% | 95.4 |
Because they have passed COVID-19 | 8.0% | 92.0% |
Prefer to wait to see how they work | 5.7% | 94.3% |
Against all vaccines in general | 3.4% | 96.6% |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pérez-Bermejo, M.; Cloquell-Lozano, A.; Moret-Tatay, C.; Arteaga-Moreno, F.J. Social Vulnerability and COVID-19 Vaccine in Spain. Int. J. Environ. Res. Public Health 2022, 19, 14013. https://doi.org/10.3390/ijerph192114013
Pérez-Bermejo M, Cloquell-Lozano A, Moret-Tatay C, Arteaga-Moreno FJ. Social Vulnerability and COVID-19 Vaccine in Spain. International Journal of Environmental Research and Public Health. 2022; 19(21):14013. https://doi.org/10.3390/ijerph192114013
Chicago/Turabian StylePérez-Bermejo, Marcelino, Alexis Cloquell-Lozano, Carmen Moret-Tatay, and Francisco Javier Arteaga-Moreno. 2022. "Social Vulnerability and COVID-19 Vaccine in Spain" International Journal of Environmental Research and Public Health 19, no. 21: 14013. https://doi.org/10.3390/ijerph192114013
APA StylePérez-Bermejo, M., Cloquell-Lozano, A., Moret-Tatay, C., & Arteaga-Moreno, F. J. (2022). Social Vulnerability and COVID-19 Vaccine in Spain. International Journal of Environmental Research and Public Health, 19(21), 14013. https://doi.org/10.3390/ijerph192114013